57894-501Level 3
Rybrevant (amivantamab-vmjw)
**Product type:** Human Prescription Drug
**Active ingredient:** AMIVANTAMAB
**Strength:** 350 mg/1
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Janssen Biotech, Inc.
**Marketing category:** BLA (BLA761210)
GET
/api/v1/systems/ndc_fda/nodes/57894-501Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.